Wei Wang is a highly experienced researcher with a focus on biochemical and biophysical properties pertinent to neurodegenerative diseases, particularly Parkinson's disease. Currently serving as a Senior Research Advisor at Eli Lilly and Company since December 2016, Wei's career also includes a role as a Research Scientist at Grifols and a Research Associate position at Indiana University School of Medicine from 2010 to 2014. Academic training includes a PhD in Chemistry from Washington University in St. Louis, complemented by a Bachelor of Science in Chemistry from Nanjing University. Wei's extensive expertise encompasses the development of novel therapeutic approaches, the characterization of synthetic ion transporters, and the synthesis of dopamine receptor ligands for drug candidate screening.
This person is not in the org chart
This person is not in any teams
This person is not in any offices